Hereditary Transthyretin Amyloidosis with Polyneuropathy: Monitoring and Management.

Valentina Vélez-SantamaríaVelina Nedkova-HristovaMoisés Morales de la PridaCarlos Casasnovas

Published in: International journal of general medicine (2022)

Our aim in this review is to discuss current treatments and investigational products and their effect on patients with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) and provide suggestions for monitoring disease progression and treatment efficacy.

Keyphrases

multiple myeloma
wild type
randomized controlled trial
clinical trial
phase ii